TreeWAS – Variant ID: rs1380836

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T39.0 Salicylates	0.000	0.980	0.020
J69.0 Pneumonitis due to food and vomit	0.000	0.981	0.019
Z85.8 Personal history of malignant neoplasms of other organs and systems	0.018	0.982	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.983	0.017
T39.1 4-Aminophenol derivatives	0.000	0.985	0.015
K11.2 Sialoadenitis	0.014	0.986	0.000
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.000	0.986	0.014
M80.9 Unspecified osteoporosis with pathological fracture	0.000	0.986	0.014
M80.98 Unspecified osteoporosis with pathological fracture (Other)	0.000	0.986	0.014
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.986	0.014
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.986	0.014
K10.8 Other specified diseases of jaws	0.013	0.987	0.000
M54.49 Lumbago with sciatica (Site unspecified)	0.013	0.987	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.987	0.013
T39.4 Antirheumatics, not elsewhere classified	0.000	0.987	0.012
T39.2 Pyrazolone derivatives	0.000	0.987	0.012
J69 Pneumonitis due to solids and liquids	0.000	0.988	0.012
M80 Osteoporosis with pathological fracture	0.000	0.989	0.011
M80.99 Unspecified osteoporosis with pathological fracture (Site unspecified)	0.000	0.989	0.011
M80.95 Unspecified osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.989	0.010
M80.97 Unspecified osteoporosis with pathological fracture (Ankle and foot)	0.000	0.990	0.010
M80.96 Unspecified osteoporosis with pathological fracture (Lower leg)	0.000	0.990	0.010
M80.94 Unspecified osteoporosis with pathological fracture (Hand)	0.000	0.990	0.010
M80.93 Unspecified osteoporosis with pathological fracture (Forearm)	0.000	0.990	0.010
M80.92 Unspecified osteoporosis with pathological fracture (Upper arm)	0.000	0.990	0.010
M80.91 Unspecified osteoporosis with pathological fracture (Shoulder region)	0.000	0.990	0.010
M80.1 Postoophorectomy osteoporosis with pathological fracture	0.000	0.990	0.010
M80.10 Postoophorectomy osteoporosis with pathological fracture (Multiple sites)	0.000	0.990	0.010
J69.8 Pneumonitis due to other solids and liquids	0.000	0.990	0.010
M54.46 Lumbago with sciatica (Lumbar region)	0.009	0.991	0.000
K11 Diseases of salivary glands	0.009	0.991	0.000
J69.1 Pneumonitis due to oils and essences	0.000	0.991	0.009
M80.0 Postmenopausal osteoporosis with pathological fracture	0.000	0.991	0.009
M54.4 Lumbago with sciatica	0.009	0.991	0.000
K10 Other diseases of jaws	0.009	0.991	0.000
K11.8 Other diseases of salivary glands	0.009	0.991	0.000
D23.5 Skin of trunk	0.009	0.991	0.000
I49.9 Cardiac arrhythmia, unspecified	0.009	0.991	0.000
I50.1 Left ventricular failure	0.008	0.992	0.000
K11.3 Abscess of salivary gland	0.008	0.992	0.000
M80.8 Other osteoporosis with pathological fracture	0.000	0.992	0.008
M80.4 Drug-induced osteoporosis with pathological fracture	0.000	0.992	0.008
M80.3 Postsurgical malabsorption osteoporosis with pathological fracture	0.000	0.992	0.008
M80.2 Osteoporosis of disuse with pathological fracture	0.000	0.992	0.008
M80.5 Idiopathic osteoporosis with pathological fracture	0.000	0.992	0.008
M80.19 Postoophorectomy osteoporosis with pathological fracture (Site unspecified)	0.000	0.992	0.008
M80.18 Postoophorectomy osteoporosis with pathological fracture (Other)	0.000	0.992	0.008
M80.17 Postoophorectomy osteoporosis with pathological fracture (Ankle and foot)	0.000	0.992	0.008
M80.16 Postoophorectomy osteoporosis with pathological fracture (Lower leg)	0.000	0.992	0.008
M80.15 Postoophorectomy osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.992	0.008
M80.14 Postoophorectomy osteoporosis with pathological fracture (Hand)	0.000	0.992	0.008
M80.13 Postoophorectomy osteoporosis with pathological fracture (Forearm)	0.000	0.992	0.008
M80.12 Postoophorectomy osteoporosis with pathological fracture (Upper arm)	0.000	0.992	0.008
M80.11 Postoophorectomy osteoporosis with pathological fracture (Shoulder region)	0.000	0.992	0.008
M80.00 Postmenopausal osteoporosis with pathological fracture (Multiple sites)	0.000	0.992	0.008
K11.1 Hypertrophy of salivary gland	0.008	0.992	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.992	0.008
K10.9 Disease of jaws, unspecified	0.007	0.993	0.000
K10.1 Giant cell granuloma, central	0.007	0.993	0.000
K10.2 Inflammatory conditions of jaws	0.007	0.993	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.993	0.007
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.993	0.007
K11.7 Disturbances of salivary secretion	0.007	0.993	0.000
C17.0 Duodenum	0.007	0.993	0.000
T36 Poisoning by systemic antibiotics	0.000	0.993	0.007
K11.4 Fistula of salivary gland	0.007	0.993	0.000
K11.0 Atrophy of salivary gland	0.007	0.993	0.000
N08.3 Glomerular disorders in diabetes mellitus	0.000	0.993	0.007
M54.48 Lumbago with sciatica (Sacral and sacrococcygeal region)	0.007	0.993	0.000
M54.45 Lumbago with sciatica (Thoracolumbar region)	0.007	0.993	0.000
M54.44 Lumbago with sciatica-Thoracic	0.007	0.993	0.000
M54.43 Lumbago with sciatica-Cervicothoracic	0.007	0.993	0.000
M54.42 Lumbago with sciatica-Cervical	0.007	0.993	0.000
M54.41 Lumbago with sciatica-Occipit-atl-axl	0.007	0.993	0.000
M54.40 Lumbago with sciatica (Multiple sites in spine)	0.007	0.993	0.000
M80.09 Postmenopausal osteoporosis with pathological fracture (Site unspecified)	0.000	0.993	0.007
M80.08 Postmenopausal osteoporosis with pathological fracture (Other)	0.000	0.993	0.007
M80.07 Postmenopausal osteoporosis with pathological fracture (Ankle and foot)	0.000	0.993	0.007
M80.06 Postmenopausal osteoporosis with pathological fracture (Lower leg)	0.000	0.993	0.007
M80.05 Postmenopausal osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.993	0.007
M80.04 Postmenopausal osteoporosis with pathological fracture (Hand)	0.000	0.993	0.007
M80.03 Postmenopausal osteoporosis with pathological fracture (Forearm)	0.000	0.993	0.007
M80.02 Postmenopausal osteoporosis with pathological fracture (Upper arm)	0.000	0.993	0.007
M80.01 Postmenopausal osteoporosis with pathological fracture (Shoulder region)	0.000	0.993	0.007
K10.0 Developmental disorders of jaws	0.007	0.993	0.000
C17.2 Ileum	0.007	0.993	0.000
C17 Malignant neoplasm of small intestine	0.007	0.993	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.993	0.006
T36.0 Penicillins	0.000	0.994	0.006
M80.81 Other osteoporosis with pathological fracture (Shoulder region)	0.000	0.994	0.006
K10.3 Alveolitis of jaws	0.006	0.994	0.000
M80.89 Other osteoporosis with pathological fracture (Site unspecified)	0.000	0.994	0.006
M80.87 Other osteoporosis with pathological fracture (Ankle and foot)	0.000	0.994	0.006
M80.86 Other osteoporosis with pathological fracture (Lower leg)	0.000	0.994	0.006
M80.85 Other osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.994	0.006
M80.84 Other osteoporosis with pathological fracture (Hand)	0.000	0.994	0.006
M80.83 Other osteoporosis with pathological fracture (Forearm)	0.000	0.994	0.006
M80.82 Other osteoporosis with pathological fracture (Upper arm)	0.000	0.994	0.006
M80.80 Other osteoporosis with pathological fracture (Multiple sites)	0.000	0.994	0.006
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.994	0.006
M80.29 Osteoporosis of disuse with pathological fracture (Site unspecified)	0.000	0.994	0.006
M80.28 Osteoporosis of disuse with pathological fracture (Other)	0.000	0.994	0.006
M80.27 Osteoporosis of disuse with pathological fracture (Ankle and foot)	0.000	0.994	0.006
M80.26 Osteoporosis of disuse with pathological fracture (Lower leg)	0.000	0.994	0.006
M80.25 Osteoporosis of disuse with pathological fracture (Pelvic region and thigh)	0.000	0.994	0.006
M80.24 Osteoporosis of disuse with pathological fracture (Hand)	0.000	0.994	0.006
M80.23 Osteoporosis of disuse with pathological fracture (Forearm)	0.000	0.994	0.006
M80.22 Osteoporosis of disuse with pathological fracture (Upper arm)	0.000	0.994	0.006
M80.21 Osteoporosis of disuse with pathological fracture (Shoulder region)	0.000	0.994	0.006
M80.20 Osteoporosis of disuse with pathological fracture (Multiple sites)	0.000	0.994	0.006
M80.39 Postsurgical malabsorption osteoporosis with pathological fracture (Site unspecified)	0.000	0.994	0.006
M80.38 Postsurgical malabsorption osteoporosis with pathological fracture (Other)	0.000	0.994	0.006
M80.37 Postsurgical malabsorption osteoporosis with pathological fracture (Ankle and foot)	0.000	0.994	0.006
M80.36 Postsurgical malabsorption osteoporosis with pathological fracture (Lower leg)	0.000	0.994	0.006
M80.35 Postsurgical malabsorption osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.994	0.006
M80.34 Postsurgical malabsorption osteoporosis with pathological fracture (Hand)	0.000	0.994	0.006
M80.33 Postsurgical malabsorption osteoporosis with pathological fracture (Forearm)	0.000	0.994	0.006
M80.32 Postsurgical malabsorption osteoporosis with pathological fracture (Upper arm)	0.000	0.994	0.006
M80.31 Postsurgical malabsorption osteoporosis with pathological fracture (Shoulder region)	0.000	0.994	0.006
M80.30 Postsurgical malabsorption osteoporosis with pathological fracture (Multiple sites)	0.000	0.994	0.006
M80.49 Drug-induced osteoporosis with pathological fracture (Site unspecified)	0.000	0.994	0.006
M80.48 Drug-induced osteoporosis with pathological fracture (Other)	0.000	0.994	0.006
M80.47 Drug-induced osteoporosis with pathological fracture (Ankle and foot)	0.000	0.994	0.006
M80.46 Drug-induced osteoporosis with pathological fracture (Lower leg)	0.000	0.994	0.006
M80.45 Drug-induced osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.994	0.006
M80.44 Drug-induced osteoporosis with pathological fracture (Hand)	0.000	0.994	0.006
M80.43 Drug-induced osteoporosis with pathological fracture (Forearm)	0.000	0.994	0.006
M80.42 Drug-induced osteoporosis with pathological fracture (Upper arm)	0.000	0.994	0.006
M80.41 Drug-induced osteoporosis with pathological fracture (Shoulder region)	0.000	0.994	0.006
M80.40 Drug-induced osteoporosis with pathological fracture (Multiple sites)	0.000	0.994	0.006
M80.52 Idiopathic osteoporosis with pathological fracture (Upper arm)	0.000	0.994	0.006
C17.9 Small intestine, unspecified	0.006	0.994	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.994	0.006
M80.59 Idiopathic osteoporosis with pathological fracture (Site unspecified)	0.000	0.994	0.006
M80.58 Idiopathic osteoporosis with pathological fracture (Other)	0.000	0.994	0.006
M80.57 Idiopathic osteoporosis with pathological fracture (Ankle and foot)	0.000	0.994	0.006
M80.56 Idiopathic osteoporosis with pathological fracture (Lower leg)	0.000	0.994	0.006
M80.55 Idiopathic osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.994	0.006
M80.54 Idiopathic osteoporosis with pathological fracture (Hand)	0.000	0.994	0.006
M80.53 Idiopathic osteoporosis with pathological fracture (Forearm)	0.000	0.994	0.006
M80.51 Idiopathic osteoporosis with pathological fracture (Shoulder region)	0.000	0.994	0.006
M80.88 Other osteoporosis with pathological fracture (Other)	0.000	0.994	0.006
C17.1 Jejunum	0.006	0.994	0.000
J60-J70 Lung diseases due to external agents	0.000	0.994	0.006
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.994	0.006
T50.4 Drugs affecting uric acid metabolism	0.000	0.994	0.006
K11.5 Sialolithiasis	0.006	0.994	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.994	0.005
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.994	0.005
T37.5 Antiviral drugs	0.000	0.994	0.005
T37.4 Anthelminthics	0.000	0.994	0.005
T37.3 Other antiprotozoal drugs	0.000	0.994	0.005
T37.1 Antimycobacterial drugs	0.000	0.994	0.005
T37.0 Sulphonamides	0.000	0.994	0.005
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.995	0.005
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.995	0.005
T36.3 Macrolides	0.000	0.995	0.005
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.995	0.005
K11.6 Mucocele of salivary gland	0.005	0.995	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.995	0.005
M80.50 Idiopathic osteoporosis with pathological fracture (Multiple sites)	0.000	0.995	0.005
T36.8 Other systemic antibiotics	0.000	0.995	0.005
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.995	0.005
J67.2 Bird fancier's lung	0.000	0.995	0.005
J67 Hypersensitivity pneumonitis due to organic dust	0.000	0.995	0.005
T36.9 Systemic antibiotic, unspecified	0.000	0.995	0.005
T36.7 Antifungal antibiotics, systemically used	0.000	0.995	0.005
T36.6 Rifamycins	0.000	0.995	0.005
T36.5 Aminoglycosides	0.000	0.995	0.005
T36.2 Chloramphenicol group	0.000	0.995	0.005
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.995	0.005
T45.2 Vitamins, not elsewhere classified	0.000	0.995	0.005
T36.4 Tetracyclines	0.000	0.995	0.005
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.995	0.005
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.995	0.005
M54.47 Lumbago with sciatica (Lumbosacral region)	0.005	0.995	0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.000	0.995	0.005
M70.65 Trochanteric bursitis-Pelvic/Thigh	0.000	0.995	0.005
C17.8 Overlapping lesion of small intestine	0.005	0.995	0.000
C17.3 Meckel's diverticulum	0.005	0.995	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.995	0.005
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.995	0.005
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.995	0.005
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.995	0.005
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.995	0.005
T44.0 Anticholinesterase agents	0.000	0.995	0.005
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.995	0.005
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.995	0.005
J60 Coalworker's pneumoconiosis	0.000	0.995	0.005
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.995	0.005
K11.9 Disease of salivary gland, unspecified	0.005	0.995	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.995	0.005
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.995	0.005
T50.8 Diagnostic agents	0.000	0.995	0.005
J64 Unspecified pneumoconiosis	0.000	0.995	0.005
T48.5 Anti-common-cold drugs	0.000	0.995	0.004
T50.7 Analeptics and opioid receptor antagonists	0.000	0.995	0.004
T50.5 Appetite depressants	0.000	0.995	0.004
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.995	0.004
T50.0 Mineralocorticoids and their antagonists	0.000	0.995	0.004
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.995	0.004
J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours	0.000	0.996	0.004
J66 Airway disease due to specific organic dust	0.000	0.996	0.004
J63 Pneumoconiosis due to other inorganic dusts	0.000	0.996	0.004
J65 Pneumoconiosis associated with tuberculosis	0.000	0.996	0.004
T49.9 Topical agent, unspecified	0.000	0.996	0.004
T49.8 Other topical agents	0.000	0.996	0.004
T49.7 Dental drugs, topically applied	0.000	0.996	0.004
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.996	0.004
T49.5 Ophthalmological drugs and preparations	0.000	0.996	0.004
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.996	0.004
T49.3 Emollients, demulcents and protectants	0.000	0.996	0.004
T49.2 Local astringents and local detergents	0.000	0.996	0.004
T49.1 Antipruritics	0.000	0.996	0.004
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.996	0.004
T50.1 Loop [high-ceiling] diuretics	0.000	0.996	0.004
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.996	0.004
B80 Enterobiasis	0.004	0.996	0.000
J70 Respiratory conditions due to other external agents	0.000	0.996	0.004
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.996	0.004
T46.7 Peripheral vasodilators	0.000	0.996	0.004
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.996	0.004
D22.0 Melanocytic naevi of lip	0.000	0.996	0.004
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.996	0.004
T45.8 Other primarily systemic and haematological agents	0.000	0.996	0.004
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.996	0.004
T45.6 Fibrinolysis-affecting drugs	0.000	0.996	0.004
T45.3 Enzymes, not elsewhere classified	0.000	0.996	0.004
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.996	0.004
T48.4 Expectorants	0.000	0.996	0.004
T48.3 Antitussives	0.000	0.996	0.004
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.996	0.004
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.996	0.004
T48.0 Oxytocic drugs	0.000	0.996	0.004
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.996	0.004
T38.9 Other and unspecified hormone antagonists	0.000	0.996	0.004
T38.7 Androgens and anabolic congeners	0.000	0.996	0.004
T38.4 Oral contraceptives	0.000	0.996	0.004
T38.2 Antithyroid drugs	0.000	0.996	0.004
T45.0 Antiallergic and antiemetic drugs	0.000	0.996	0.004
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.996	0.004
J62 Pneumoconiosis due to dust containing silica	0.000	0.996	0.004
T42.4 Benzodiazepines	0.000	0.996	0.004
T41.5 Therapeutic gases	0.000	0.996	0.004
T41.4 Anaesthetic, unspecified	0.000	0.996	0.004
T41.3 Local anaesthetics	0.000	0.996	0.004
T41.1 Intravenous anaesthetics	0.000	0.996	0.004
T41.0 Inhaled anaesthetics	0.000	0.996	0.004
T45.4 Iron and its compounds	0.000	0.996	0.004
T38.0 Glucocorticoids and synthetic analogues	0.000	0.996	0.004
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.996	0.004
J67.7 Air-conditioner and humidifier lung	0.000	0.996	0.004
J67.6 Maple-bark-stripper's lung	0.000	0.996	0.004
J67.5 Mushroom-worker's lung	0.000	0.996	0.004
J67.4 Maltworker's lung	0.000	0.996	0.004
J67.3 Suberosis	0.000	0.996	0.004
J67.1 Bagassosis	0.000	0.996	0.004
J67.0 Farmer's lung	0.000	0.996	0.004
I42.9 Cardiomyopathy, unspecified	0.004	0.996	0.000
J67.9 Hypersensitivity pneumonitis due to unspecified organic dust	0.000	0.996	0.004
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.996	0.004
T38.1 Thyroid hormones and substitutes	0.000	0.996	0.004
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.996	0.004
T38.5 Other oestrogens and progestogens	0.000	0.996	0.004
T41.2 Other and unspecified general anaesthetics	0.000	0.996	0.004
K76.9 Liver disease, unspecified	0.004	0.996	0.000
T45.5 Anticoagulants	0.000	0.996	0.004
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.996	0.003
J67.8 Hypersensitivity pneumonitis due to other organic dusts	0.000	0.996	0.003
I42.1 Obstructive hypertrophic cardiomyopathy	0.004	0.996	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.996	0.003
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.997	0.003
J70.4 Drug-induced interstitial lung disorder, unspecified	0.000	0.997	0.003
N89.8 Other specified noninflammatory disorders of vagina	0.003	0.997	0.000
J63.8 Pneumoconiosis due to other specified inorganic dusts	0.000	0.997	0.003
J63.5 Stannosis	0.000	0.997	0.003
J63.4 Siderosis	0.000	0.997	0.003
J63.3 Graphite fibrosis (of lung)	0.000	0.997	0.003
J63.2 Berylliosis	0.000	0.997	0.003
J63.1 Bauxite fibrosis (of lung)	0.000	0.997	0.003
J63.0 Aluminosis (of lung)	0.000	0.997	0.003
J66.8 Airway disease due to other specific organic dusts	0.000	0.997	0.003
J66.2 Cannabinosis	0.000	0.997	0.003
J66.1 Flax-dresser's disease	0.000	0.997	0.003
J66.0 Byssinosis	0.000	0.997	0.003
J68.9 Unspecified respiratory condition due to chemicals, gases, fumes and vapours	0.000	0.997	0.003
J68.8 Other respiratory conditions due to chemicals, gases, fumes and vapours	0.000	0.997	0.003
J68.4 Chronic respiratory conditions due to chemicals, gases, fumes and vapours	0.000	0.997	0.003
J68.3 Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours	0.000	0.997	0.003
J68.2 Upper respiratory inflammation due to chemicals, gases, fumes and vapours, not elsewhere classified	0.000	0.997	0.003
J68.1 Acute pulmonary oedema due to chemicals, gases, fumes and vapours	0.000	0.997	0.003
J68.0 Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours	0.000	0.997	0.003
C90.0 Multiple myeloma	0.000	0.997	0.003
I42 Cardiomyopathy	0.003	0.997	0.000
J70.9 Respiratory conditions due to unspecified external agent	0.000	0.997	0.003
J70.8 Respiratory conditions due to other specified external agents	0.000	0.997	0.003
J70.3 Chronic drug-induced interstitial lung disorders	0.000	0.997	0.003
J70.2 Acute drug-induced interstitial lung disorders	0.000	0.997	0.003
J70.0 Acute pulmonary manifestations due to radiation	0.000	0.997	0.003
T47.2 Stimulant laxatives	0.000	0.997	0.003
J62.0 Pneumoconiosis due to talc dust	0.000	0.997	0.003
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.997	0.003
T42.2 Succinimides and oxazolidinediones	0.000	0.997	0.003
Z12.0 Special screening examination for neoplasm of stomach	0.000	0.997	0.003
I42.2 Other hypertrophic cardiomyopathy	0.003	0.997	0.000
T46.1 Calcium-channel blockers	0.000	0.997	0.003
I42.8 Other cardiomyopathies	0.003	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.003
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.003
T47.7 Emetics	0.000	0.997	0.003
T47.5 Digestants	0.000	0.997	0.003
T47.3 Saline and osmotic laxatives	0.000	0.997	0.003
T42.3 Barbiturates	0.000	0.997	0.003
J70.1 Chronic and other pulmonary manifestations due to radiation	0.000	0.997	0.003
D37.4 Colon	0.003	0.997	0.000
J62.8 Pneumoconiosis due to other dust containing silica	0.000	0.997	0.003
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.997	0.003
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.997	0.003
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.997	0.003
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.997	0.003
T47.6 Antidiarrhoeal drugs	0.000	0.997	0.003
J86.9 Pyothorax without fistula	0.000	0.997	0.003
T47.4 Other laxatives	0.000	0.997	0.003
B37.3 Candidiasis of vulva and vagina	0.003	0.997	0.000
G83.4 Cauda equina syndrome	0.003	0.997	0.000
T42.1 Iminostilbenes	0.000	0.997	0.003
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
T42.0 Hydantoin derivatives	0.000	0.997	0.003
D73.0 Hyposplenism	0.000	0.997	0.003
I42.3 Endomyocardial (eosinophilic) disease	0.003	0.997	0.000
N85.8 Other specified noninflammatory disorders of uterus	0.003	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.000	0.997	0.002
K75.4 Autoimmune hepatitis	0.000	0.997	0.003
I42.5 Other restrictive cardiomyopathy	0.003	0.997	0.000
N81.4 Uterovaginal prolapse, unspecified	0.000	0.997	0.003
Q50.4 Embryonic cyst of Fallopian tube	0.003	0.997	0.000
D48.6 Breast	0.003	0.997	0.000
I42.4 Endocardial fibroelastosis	0.003	0.997	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
M31 Other necrotising vasculopathies	0.003	0.997	0.000
M31.0 Hypersensitivity angiitis	0.003	0.997	0.000
I42.6 Alcoholic cardiomyopathy	0.002	0.997	0.000
I42.0 Dilated cardiomyopathy	0.003	0.997	0.000
M31.9 Necrotising vasculopathy, unspecified	0.002	0.997	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.997	0.002
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.998	0.002
R60.0 Localised oedema	0.002	0.998	0.000
B37.0 Candidal stomatitis	0.002	0.998	0.000
E16.2 Hypoglycaemia, unspecified	0.000	0.998	0.002
M31.5 Giant cell arteritis with polymyalgia rheumatica	0.002	0.998	0.000
S42.40 Fracture of lower end of humerus (closed)	0.000	0.998	0.002
S62.61 Fracture of other finger (open)	0.000	0.998	0.002
E85.4 Organ-limited amyloidosis	0.002	0.998	0.000
G83.8 Other specified paralytic syndromes	0.002	0.998	0.000
M31.7 Microscopic polyangiitis	0.002	0.998	0.000
L73.9 Follicular disorder, unspecified	0.000	0.998	0.002
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
M43.16 Spondylolisthesis (Lumbar region)	0.002	0.998	0.000
I42.7 Cardiomyopathy due to drugs and other external agents	0.002	0.998	0.000
M31.4 Aortic arch syndrome [Takayasu]	0.002	0.998	0.000
M31.1 Thrombotic microangiopathy	0.002	0.998	0.000
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.000	0.998	0.002
H35.7 Separation of retinal layers	0.000	0.998	0.002
I82.2 Embolism and thrombosis of vena cava	0.000	0.998	0.002
L73.2 Hidradenitis suppurativa	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
M31.6 Other giant cell arteritis	0.002	0.998	0.000
G83 Other paralytic syndromes	0.002	0.998	0.000
M06.40 Inflammatory polyarthropathy (Multiple sites)	0.000	0.998	0.002
K70.3 Alcoholic cirrhosis of liver	0.000	0.998	0.002
M31.3 Wegener's granulomatosis	0.002	0.998	0.000
M70.6 Trochanteric bursitis	0.000	0.998	0.002
D37.6 Liver, gallbladder and bile ducts	0.002	0.998	0.000
D37.0 Lip, oral cavity and pharynx	0.002	0.998	0.000
T43.2 Other and unspecified antidepressants	0.000	0.998	0.002
T81.2 Accidental puncture and laceration during a procedure, not elsewhere classified	0.002	0.998	0.000
D25.2 Subserosal leiomyoma of uterus	0.002	0.998	0.000
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.000	0.998	0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.998	0.002
B37.9 Candidiasis, unspecified	0.002	0.998	0.000
G83.9 Paralytic syndrome, unspecified	0.002	0.998	0.000
I33.0 Acute and subacute infective endocarditis	0.000	0.998	0.002
I82.8 Embolism and thrombosis of other specified veins	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.002	0.998	0.000
M31.2 Lethal midline granuloma	0.002	0.998	0.000
I50 Heart failure	0.002	0.998	0.000
G83.1 Monoplegia of lower limb	0.002	0.998	0.000
S82.60 Fracture of lateral malleolus (closed)	0.002	0.998	0.000
B49 Unspecified mycosis	0.002	0.998	0.000
D37.9 Digestive organ, unspecified	0.002	0.998	0.000
H73.9 Disorder of tympanic membrane, unspecified	0.000	0.998	0.002
M31.8 Other specified necrotising vasculopathies	0.002	0.998	0.000
B37 Candidiasis	0.002	0.998	0.000
G83.3 Monoplegia, unspecified	0.002	0.998	0.000
I50.0 Congestive heart failure	0.002	0.998	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.002
D37.7 Other digestive organs	0.002	0.998	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
M70.68 Trochanteric bursitis-Other	0.000	0.998	0.002
M70.67 Trochanteric bursitis-Ankle/Foot	0.000	0.998	0.002
M70.66 Trochanteric bursitis-Lower Leg	0.000	0.998	0.002
M70.64 Trochanteric bursitis-Hand	0.000	0.998	0.002
M70.63 Trochanteric bursitis-Forearm	0.000	0.998	0.002
M70.62 Trochanteric bursitis-Upper arm	0.000	0.998	0.002
M70.61 Trochanteric bursitis-Shldr region	0.000	0.998	0.002
M70.60 Trochanteric bursitis-Mult sites	0.000	0.998	0.002
G83.5 Locked-in syndrome	0.002	0.998	0.000
G83.0 Diplegia of upper limbs	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.000	0.998	0.002
M06.0 Seronegative rheumatoid arthritis	0.000	0.998	0.002
D14.1 Larynx	0.000	0.998	0.002
L98.8 Other specified disorders of skin and subcutaneous tissue	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.998	0.002
T40.8 Lysergide [LSD]	0.000	0.998	0.002
T40.7 Cannabis (derivatives)	0.000	0.998	0.002
T40.0 Opium	0.000	0.998	0.002
N08 Glomerular disorders in diseases classified elsewhere	0.000	0.998	0.002
B37.2 Candidiasis of skin and nail	0.002	0.998	0.000
D37.2 Small intestine	0.002	0.998	0.000
J86 Pyothorax	0.000	0.998	0.002
M65.43 Radial styloid tenosynovitis [de Quervain] (Forearm)	0.000	0.998	0.002
B37.4 Candidiasis of other urogenital sites	0.002	0.998	0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.002	0.998	0.000
H35.8 Other specified retinal disorders	0.000	0.998	0.002
K70.9 Alcoholic liver disease, unspecified	0.000	0.998	0.002
T51.0 Ethanol	0.000	0.998	0.002
B65-B83 Helminthiases	0.002	0.998	0.000
S82.31 Fracture of lower end of tibia (open)	0.000	0.998	0.002
S82.30 Fracture of lower end of tibia (closed)	0.000	0.998	0.002
I22.0 Subsequent myocardial infarction of anterior wall	0.002	0.998	0.000
T40.1 Heroin	0.000	0.998	0.002
M70.69 Trochanteric bursitis-Site unspec	0.000	0.998	0.002
C92.0 Acute myeloid leukaemia	0.002	0.998	0.000
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.000	0.998	0.002
M82.11 Osteoporosis in endocrine disorders (Shoulder region)	0.000	0.998	0.002
H35.9 Retinal disorder, unspecified	0.000	0.998	0.002
C92.1 Chronic myeloid leukaemia	0.002	0.998	0.000
I69.3 Sequelae of cerebral infarction	0.000	0.998	0.002
O32.0 Maternal care for unstable lie	0.000	0.998	0.002
B37.6 Candidal endocarditis	0.002	0.998	0.000
B37.5 Candidal meningitis	0.002	0.998	0.000
D14.0 Middle ear, nasal cavity and accessory sinuses	0.000	0.998	0.002
T40.5 Cocaine	0.000	0.998	0.001
Q50.5 Embryonic cyst of broad ligament	0.002	0.998	0.000
I82 Other venous embolism and thrombosis	0.000	0.998	0.002
C92.5 Acute myelomonocytic leukaemia	0.002	0.998	0.000
T40.3 Methadone	0.000	0.998	0.001
C92 Myeloid leukaemia	0.002	0.998	0.000
C92.2 Subacute myeloid leukaemia	0.002	0.998	0.000
M82.1 Osteoporosis in endocrine disorders	0.000	0.998	0.002
O34.7 Maternal care for abnormality of vulva and perineum	0.002	0.998	0.000
L73 Other follicular disorders	0.000	0.998	0.002
M06.08 Seronegative rheumatoid arthritis (Other)	0.000	0.998	0.001
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)	0.000	0.998	0.001
M06.03 Seronegative rheumatoid arthritis (Forearm)	0.000	0.998	0.001
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.000	0.998	0.001
D14.3 Bronchus and lung	0.000	0.998	0.002
G83.2 Monoplegia of upper limb	0.001	0.998	0.000
I82.0 Budd-Chiari syndrome	0.000	0.998	0.002
N08.8 Glomerular disorders in other diseases classified elsewhere	0.000	0.998	0.001
N08.1 Glomerular disorders in neoplastic diseases	0.000	0.998	0.001
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.001
M82 Osteoporosis in diseases classified elsewhere	0.000	0.998	0.002
D37.5 Rectum	0.002	0.998	0.000
H73.8 Other specified disorders of tympanic membrane	0.000	0.998	0.002
Q50.6 Other congenital malformatons of Fallopian tube and broad ligament	0.001	0.998	0.000
Q50.3 Other congenital malformations of ovary	0.001	0.998	0.000
Q50.2 Congenital torsion of ovary	0.001	0.998	0.000
Q50.1 Developmental ovarian cyst	0.001	0.998	0.000
Q50.0 Congenital absence of ovary	0.001	0.998	0.000
B83 Other helminthiases	0.001	0.998	0.000
B81 Other intestinal helminthiases, not elsewhere classified	0.001	0.998	0.000
B78 Strongyloidiasis	0.001	0.998	0.000
B77 Ascariasis	0.001	0.998	0.000
B76 Hookworm diseases	0.001	0.998	0.000
B74 Filariasis	0.001	0.998	0.000
B71 Other cestode infections	0.001	0.998	0.000
B70 Diphyllobothriasis and sparganosis	0.001	0.998	0.000
B69 Cysticercosis	0.001	0.998	0.000
B68 Taeniasis	0.001	0.998	0.000
B67 Echinococcosis	0.001	0.998	0.000
B66 Other fluke infections	0.001	0.998	0.000
B65 Schistosomiasis [bilharziasis]	0.001	0.998	0.000
B79 Trichuriasis	0.001	0.998	0.000
B75 Trichinellosis	0.001	0.998	0.000
B73 Onchocerciasis	0.001	0.998	0.000
B72 Dracunculiasis	0.001	0.998	0.000
M80-M85 Disorders of bone density and structure	0.000	0.998	0.002
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.000	0.998	0.002
M06.06 Seronegative rheumatoid arthritis (Lower leg)	0.000	0.998	0.001
M19.27 Other secondary arthrosis (Ankle and foot)	0.000	0.998	0.002
B37.7 Candidal septicaemia	0.001	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.001	0.998	0.000
J86.0 Pyothorax with fistula	0.000	0.998	0.001
K70.1 Alcoholic hepatitis	0.000	0.998	0.002
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.000	0.998	0.001
K70 Alcoholic liver disease	0.000	0.998	0.002
C92.4 Acute promyelocytic leukaemia	0.001	0.998	0.000
I82.3 Embolism and thrombosis of renal vein	0.000	0.998	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations